These trials confirmed clinically sizeable pharmacokinetic interactions [7] characterized by a decrease in the clearance of the anticancer drug and hence amplified exposure. The interpretation of subsequent phase II and III clinical trials was complex as it was not possible to administer the same dose of chemotherapy during the presence https://beckettmswad.blogspothub.com/27655818/little-known-facts-about-bms-199264-hydrochloride